The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,367,658 in first-year total cost, median $346,237.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-C (10)]4
- Special Emphasis Panel[ZRG1 SBIB-T (10)]3
- Special Emphasis Panel[ZRG1 IMST-V (15)]2
- Special Emphasis Panel[ZRG1 ETTN-M (11)]1
- Special Emphasis Panel[ZRG1 HDM-R (11)]1
Most frequent institutions
- ACTIVE MOTIF, INC.2
- EXOCYTRONICS, LLC2
- BIOSPEECH, INC.1
- IMPEL NEUROPHARMA, INC.1
- LEAFLABS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | ClearScope1R44MH116827-01 | GLASER, JACOB R | MICROBRIGHTFIELD, LLC, VT | $556,615 | ZRG1 |
| 2018 | High sensitivity tethered bichromophoric voltage-sensitive dyes1R43MH116830-01A1 | ACKER, COREY | POTENTIOMETRIC PROBES, LLC, CT | $225,000 | ZRG1 |
| 2017 | High channel count electrophysiology and data processing for freely-moving animals1R44MH114783-01 | KINNEY, JUSTIN PSHEPARD, KENNETH L | LEAFLABS, LLC, MA | $699,043 | ZRG1 |
| 2017 | The Development of a Resonant Scanning MMM system for high resolution 3D CNS imaging1R43MH115635-01 | YEW, YAN SENG ELIJAH | TISSUEVISION, INC., MA | $533,312 | ZRG1 |
| 2016 | Tool for non-invasive delivery of central nervous system drug candidates2R44MH099720-03A1 | HOEKMAN, JOHN | IMPEL NEUROPHARMA, INC., WA | $914,222 | ZRG1 |
| 2016 | Scalable amperometric microchip array for high-throughput screening of small molecules, peptides or genetic perturbations for modulation of quantal transmitter release1R43MH109212-01A1 | LINDAU, MANFREDLIU, XIN ALICE | EXOCYTRONICS, LLC, MO | $444,519 | ZRG1 |
| 2016 | Method for de novo Discovery of Locus Specific Regulatory Elements1R43MH111294-01 | KELLY, THERESA K. | ACTIVE MOTIF, INC., CA | $225,000 | ZRG1 |
| 2016 | Prosody Assessment Toolbox1R44DC015145-01 | CONNORS, PAMELA ALLISON | BIOSPEECH, INC., OR | $224,044 | ZRG1 |
| 2016 | Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders1R43MH109190-01 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $223,681 | ZRG1 |
| 2016 | SCALABLE MULTIPLEXED MICROARRAY ASSAY FOR RECEPTOR DOWNREGULATION1R43MH111295-01 | ASBURY, G. REID | SPECTRAGENETICS, PA | $213,765 | ZRG1 |
| 2015 | Development of a prototype system for assaying exocytosis from individual cells using using transparent microelectrode arrays2R44MH096650-03A1 | GILLIS, KEVIN DGU, LI-QUN (ANDREW)LIU, XIN ALICE | EXOCYTRONICS, LLC, MO | $538,002 | ZRG1 |
| 2015 | PDE4D PET Ligand for Psychiatric Disease1R43MH107077-01 | GURNEY, MARK E | TETRA DISCOVERY PARTNERS, INC., MI | $346,237 | ZRG1 |
| 2015 | Neurobiology toolbox for identification of lncRNA targets and associated proteins1R43MH107083-01 | KELLY, THERESA K. | ACTIVE MOTIF, INC., CA | $224,218 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.